Turn recording back on
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.
Pickard AS, Neary MP, Cella D.
Health Qual Life Outcomes. 2007 Dec 21;5:70.
PMID: 18154669 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU.
Chest. 2006 Oct;130(4):1117-28.
PMID: 17035446 [PubMed - indexed for MEDLINE]
Related Articles
Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
Trippoli S, Vaiani M, Lucioni C, Messori A.
Pharmacoeconomics. 2001;19(8):855-63.
PMID: 11596837 [PubMed - indexed for MEDLINE]
US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
Huang IC, Willke RJ, Atkinson MJ, Lenderking WR, Frangakis C, Wu AW.
Qual Life Res. 2007 Aug;16(6):1065-72. Epub 2007 Apr 6.
PMID: 17415683 [PubMed - indexed for MEDLINE]
The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
Günther OH, Roick C, Angermeyer MC, König HH.
J Affect Disord. 2008 Jan;105(1-3):81-91. Epub 2007 May 29.
PMID: 17532051 [PubMed - indexed for MEDLINE]
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
Walters SJ, Brazier JE.
Qual Life Res. 2005 Aug;14(6):1523-32. Review.
PMID: 16110932 [PubMed - indexed for MEDLINE]
Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
Yost KJ, Sorensen MV, Hahn EA, Glendenning GA, Gnanasakthy A, Cella D.
Value Health. 2005 Mar-Apr;8(2):117-27.
PMID: 15804320 [PubMed - indexed for MEDLINE]
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
Cella D, Eton DT, Fairclough DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH.
J Clin Epidemiol. 2002 Mar;55(3):285-95.
PMID: 11864800 [PubMed - indexed for MEDLINE]
A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes.
Sakthong P, Charoenvisuthiwongs R, Shabunthom R.
Health Qual Life Outcomes. 2008 Sep 23;6:71.
PMID: 18811935 [PubMed - indexed for MEDLINE]
Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF, Buskens E.
Health Qual Life Outcomes. 2006 Mar 25;4:20.
PMID: 16563170 [PubMed - indexed for MEDLINE]
Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM, Martin ML, Ricci JF, Bracco A.
Value Health. 2006 Mar-Apr;9(2):90-7.
PMID: 16626412 [PubMed - indexed for MEDLINE]
Validation of the EQ-5D in patients with a history of acute coronary syndrome.
Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR.
Curr Med Res Opin. 2005 Aug;21(8):1209-16.
PMID: 16083530 [PubMed - indexed for MEDLINE]
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.
Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW.
J Clin Epidemiol. 2005 Dec;58(12):1241-51. Epub 2005 Oct 13.
PMID: 16291468 [PubMed - indexed for MEDLINE]
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale.
Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, Sledge GW, Wood WC.
J Clin Epidemiol. 2004 Sep;57(9):898-910.
PMID: 15504633 [PubMed - indexed for MEDLINE]
Health utilities using the EQ-5D in studies of cancer.
Pickard AS, Wilke CT, Lin HW, Lloyd A.
Pharmacoeconomics. 2007;25(5):365-84. Review.
PMID: 17488136 [PubMed - indexed for MEDLINE]
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S, Hockley C.
Health Econ. 2005 Nov;14(11):1169-89.
PMID: 15942981 [PubMed - indexed for MEDLINE]
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA.
Health Qual Life Outcomes. 2006 Sep 27;4:71.
PMID: 17005043 [PubMed - indexed for MEDLINE]
The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ.
Int J Obes (Lond). 2007 Jan;31(1):189-96. Epub 2006 May 9.
PMID: 16682976 [PubMed - indexed for MEDLINE]
Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience.
Yost KJ, Eton DT.
Eval Health Prof. 2005 Jun;28(2):172-91.
PMID: 15851772 [PubMed - indexed for MEDLINE]
Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.
Matza LS, Secnik K, Mannix S, Sallee FR.
Pharmacoeconomics. 2005;23(8):777-90.
PMID: 16097840 [PubMed - indexed for MEDLINE]